92595 ⎘
Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
SEMICONDUCTOR DEVICE PROCESSING COMPOSITION, COMPOUND, METHOD FOR PRODUCING MODIFIED SUBSTRATE, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE
#2Alkoxy compounds for disease treatment
#3Alkoxy compounds for disease treatment
#4Alkoxy compounds for disease treatment
#5Alkoxy compounds for disease treatment
#6Alkoxy compounds for disease treatment
#7Phenoxyalkylamine compound
#8Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#9Alkoxy compounds for disease treatment
#10Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#11Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#12Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#13Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#14Amine derivative compounds for treating ophthalmic diseases and disorders
#15AMINO-PROPYLENE-GLYCOL DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#16Alkoxy compounds for disease treatment
#17Process for the synthesis of tapentadol and intermediates thereof
#18Aromatic butan-2-ol compounds and preparation and uses thereof
#19Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#20Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#21Alkoxy compounds for disease treatment
#22Alkoxy compounds for disease treatment
#23Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#24Alkoxy compounds for disease treatment
#25Amine derivative compounds for treating ophthalmic diseases and disorders
#26Amine derivative compounds for treating ophthalmic diseases and disorders
#27S1P receptors modulators
#28Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#29Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound
#30SUBSTITUTED ARYL ALKYLAMINO-OXY-ANALOGS AND USES THEREOF
#31Alkoxy compounds for disease treatment
#32Amine derivative compounds for treating ophthalmic diseases and disorders
#33Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#34Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#35Separation of stereoisomeric N,N-dialkylamino-2alkyl-3-hydroxy-3-phenylalkanes
#36Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound
#37Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
#38Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
#39Aryloxyalkylamine NK-1/SSRI inhibitors
#40Metabolites of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and their use in the treatment of urinary incontinence
#41Aminoalcohol derivatives and their use as beta 3 adrenergic agonists